LBR-101

· Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LBR-101, covering 2015-03-04 to 2022-01-24. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine [Phase 2]